The finding that TRIB3 is highly expressed in RCC has been confirmed in several studies, and the elevated TRIB3 expression in RCC patients is correlated with clinicopathologic features (e.g., tumor grade and stage) of the tumor and prognosis [19]. This evidence concerns the gene TRIB3 and neoplasm.